FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088444678> ?p ?o ?g. }

• W2088444678 endingPage "1097" @default.
• W2088444678 startingPage "1086" @default.
• W2088444678 abstract "The PI3K/AKT/mTOR pathway has been shown to play an important role in cancer. Starting with compounds 1 and 2 (GDC-0941) as templates, (thienopyrimidin-2-yl)aminopyrimidines were discovered as potent inhibitors of PI3K or both PI3K and mTOR. Structural information derived from PI3K gamma-ligand cocrystal structures of 1 and 2 were used to design inhibitors that maintained potency for PI3K yet improved metabolic stability and oral bioavailability relative to 1. The addition of a single methyl group to the optimized 5 resulted in 21, which had significantly reduced potency for mTOR. The lead compounds 5 (GNE-493) and 21 (GNE-490) have good pharmacokinetic (PK) parameters, are highly selective, demonstrate knock down of pathway markers in vivo, and are efficacious in xenograft models where the PI3K pathway is deregulated. Both compounds were compared in a PI3K alpha mutated MCF7.1 xenograft model and were found to have equivalent efficacy when normalized for exposure." @default.
• W2088444678 created "2016-06-24" @default.
• W2088444678 creator A5000814894 @default.
• W2088444678 creator A5011579222 @default.
• W2088444678 creator A5013663538 @default.
• W2088444678 creator A5014702263 @default.
• W2088444678 creator A5017935216 @default.
• W2088444678 creator A5018372628 @default.
• W2088444678 creator A5040703348 @default.
• W2088444678 creator A5046015549 @default.
• W2088444678 creator A5050767645 @default.
• W2088444678 creator A5050781087 @default.
• W2088444678 creator A5055370060 @default.
• W2088444678 creator A5056273184 @default.
• W2088444678 creator A5057116408 @default.
• W2088444678 creator A5061081453 @default.
• W2088444678 creator A5061428591 @default.
• W2088444678 creator A5064304128 @default.
• W2088444678 creator A5067239526 @default.
• W2088444678 creator A5068764000 @default.
• W2088444678 creator A5068951320 @default.
• W2088444678 creator A5069921236 @default.
• W2088444678 creator A5075660811 @default.
• W2088444678 creator A5076989067 @default.
• W2088444678 creator A5079909569 @default.
• W2088444678 creator A5081729394 @default.
• W2088444678 creator A5082178773 @default.
• W2088444678 creator A5084717735 @default.
• W2088444678 creator A5089729434 @default.
• W2088444678 creator A5090171528 @default.
• W2088444678 date "2010-01-05" @default.
• W2088444678 modified "2023-10-17" @default.
• W2088444678 title "Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer" @default.
• W2088444678 cites W1487234933 @default.
• W2088444678 cites W1529396499 @default.
• W2088444678 cites W1594020010 @default.
• W2088444678 cites W1981817858 @default.
• W2088444678 cites W2029754521 @default.
• W2088444678 cites W2035008060 @default.
• W2088444678 cites W2070732456 @default.
• W2088444678 cites W2079977894 @default.
• W2088444678 cites W2080100938 @default.
• W2088444678 cites W2107343029 @default.
• W2088444678 cites W2129172946 @default.
• W2088444678 cites W2131739722 @default.
• W2088444678 cites W2155604981 @default.
• W2088444678 cites W2158305336 @default.
• W2088444678 cites W2159530979 @default.
• W2088444678 cites W2161437969 @default.
• W2088444678 cites W2161810908 @default.
• W2088444678 cites W2388163742 @default.
• W2088444678 doi "https://doi.org/10.1021/jm901284w" @default.
• W2088444678 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20050669" @default.
• W2088444678 hasPublicationYear "2010" @default.
• W2088444678 type Work @default.
• W2088444678 sameAs 2088444678 @default.
• W2088444678 citedByCount "108" @default.
• W2088444678 countsByYear W20884446782012 @default.
• W2088444678 countsByYear W20884446782013 @default.
• W2088444678 countsByYear W20884446782014 @default.
• W2088444678 countsByYear W20884446782015 @default.
• W2088444678 countsByYear W20884446782016 @default.
• W2088444678 countsByYear W20884446782017 @default.
• W2088444678 countsByYear W20884446782018 @default.
• W2088444678 countsByYear W20884446782019 @default.
• W2088444678 countsByYear W20884446782020 @default.
• W2088444678 countsByYear W20884446782021 @default.
• W2088444678 countsByYear W20884446782022 @default.
• W2088444678 countsByYear W20884446782023 @default.
• W2088444678 crossrefType "journal-article" @default.
• W2088444678 hasAuthorship W2088444678A5000814894 @default.
• W2088444678 hasAuthorship W2088444678A5011579222 @default.
• W2088444678 hasAuthorship W2088444678A5013663538 @default.
• W2088444678 hasAuthorship W2088444678A5014702263 @default.
• W2088444678 hasAuthorship W2088444678A5017935216 @default.
• W2088444678 hasAuthorship W2088444678A5018372628 @default.
• W2088444678 hasAuthorship W2088444678A5040703348 @default.
• W2088444678 hasAuthorship W2088444678A5046015549 @default.
• W2088444678 hasAuthorship W2088444678A5050767645 @default.
• W2088444678 hasAuthorship W2088444678A5050781087 @default.
• W2088444678 hasAuthorship W2088444678A5055370060 @default.
• W2088444678 hasAuthorship W2088444678A5056273184 @default.
• W2088444678 hasAuthorship W2088444678A5057116408 @default.
• W2088444678 hasAuthorship W2088444678A5061081453 @default.
• W2088444678 hasAuthorship W2088444678A5061428591 @default.
• W2088444678 hasAuthorship W2088444678A5064304128 @default.
• W2088444678 hasAuthorship W2088444678A5067239526 @default.
• W2088444678 hasAuthorship W2088444678A5068764000 @default.
• W2088444678 hasAuthorship W2088444678A5068951320 @default.
• W2088444678 hasAuthorship W2088444678A5069921236 @default.
• W2088444678 hasAuthorship W2088444678A5075660811 @default.
• W2088444678 hasAuthorship W2088444678A5076989067 @default.
• W2088444678 hasAuthorship W2088444678A5079909569 @default.
• W2088444678 hasAuthorship W2088444678A5081729394 @default.
• W2088444678 hasAuthorship W2088444678A5082178773 @default.
• W2088444678 hasAuthorship W2088444678A5084717735 @default.
• W2088444678 hasAuthorship W2088444678A5089729434 @default.
• W2088444678 hasAuthorship W2088444678A5090171528 @default.

• next